Atorvastatin Calcium

Indications

Atorvastatin calcium tablets are an HMG-CoA reductase inhibitor (statin) indicated (1): - To reduce the risk of: - Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD. - Ml and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD. - Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD. - As an adjunct to diet to reduce low-density lipoprotein (LDL-C) in: - Adults with primary hyperlipidemia. - Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). - As an adjunct to other LDL-C-lowering therapies to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia. - As an adjunct to diet for the treatment of adults with: - Primary dysbetalipoproteinemia. - Hypertriglyceridemia.